Why the study?
While hypobetalipoproteinemia is associated with lower cardiovascular risk, studies suggest a potential risk of hepatic steatosis and complications.
Is primary hypocholesterolemia (hypobetalipoproteinemia) associated with an increased risk of hepatic complications in the general population?
Is primary hypocholesterolemia (hypobetalipoproteinemia) associated with an increased risk of hepatic complications in the general population?
Inherited extremely low LDL-C levels (hypobetalipoproteinemia) are independently associated with an increased risk of severe hepatic complications, suggesting these patients may require regular liver monitoring.
Hypobetalipoproteinemia (HBL) is a lipid disorder characterized by permanent, inherited low levels (below the 5th percentile) of low-density lipoprotein-cholesterol. While HBL is associated with a lower risk of cardiovascular events, some studies suggest that it may be associated with a potential risk of hepatic steatosis and hepatic complications. Here, we studied the association between HBL and hepatic complications (defined as cirrhosis complications and/or primary liver cancer) in two populations of several hundred thousand people, both in France (CONSTANCES cohort) and the United Kingdom (UKBB). The results show that HBL is associated with a significant and independent excess risk of hepatic complications, including primary liver cancer. Thus, in people with HBL, the value of regular liver monitoring must be studied.
No takes yet. Share an insight, caveat, or question.
Wargny et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: